/FLERIE.ST
FLERIE.ST Stock - Flerie AB (publ)
Healthcare|Drug Manufacturers - GeneralSTO
$36.35-1.76%
$0.65 (-1.76%) • Dec 23
60
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.21
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $39.99
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for FLERIE.ST
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$35.99 – $36.71
TARGET (TP)$41.80
STOP LOSS$33.44
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta-0.01
52W High$50.45
52W Low$36.00
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $100,000 | $97.50M | N/A | N/A | $35,000 |
| Gross Profit | $-41,600,000 | $93.35M | $-1,066,000 | $-1,252,000 | $-57,729,000 |
| Gross Margin | -41600.0% | 95.7% | N/A | N/A | -164940.0% |
| Operating Income | $-110,800,000 | $-107,367,000 | $-151,114,000 | $-115,630,000 | $-57,729,000 |
| Net Income | $-228,000,000 | $-95,265,000 | $-100,333,000 | $-103,043,000 | $-57,418,000 |
| Net Margin | -228000.0% | -97.7% | N/A | N/A | -164051.4% |
| EPS | $-3.24 | $-17.88 | $-18.84 | $-21.32 | $-24.25 |
Company Overview
Flerie AB (publ) is a venture capital firm specializing in early-stage investments. It seeks to invest in biotech and pharma companies engaged in drug development and associated tools or applications tackling major medical challenges of our time. The firm seeks to invest in Europe, United States and Israel. Flerie AB (publ) was founded in 2011 and is based in Stockholm, Sweden with additional office in London, United Kingdom.
Visit WebsiteLoading analyst ratings...
Earnings History & Surprises
FLERIE.STBeat Rate
0%
Last 0 quarters
Avg Surprise
+0%
EPS vs Estimate
Beats / Misses
0/0
Last 12 quarters
Latest EPS
$-1.78
Q4 2025
EPS Surprise History
Q4 23
No data
Q2 24
No data
Q3 24
No data
Q4 24
No data
Q1 25
No data
Q2 25
No data
Q3 25
No data
Q4 25
No data
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | Apr 14, 2026 | — | — | — | — |
Q1 2026 | Jan 21, 2026 | — | — | — | — |
Q4 2025 | Oct 22, 2025 | — | $-1.78 | — | — |
Q3 2025 | Jul 31, 2025 | — | $2.22 | — | — |
Q2 2025 | Apr 16, 2025 | — | $-3.22 | — | — |
Q1 2025 | Jan 22, 2025 | — | $-0.82 | — | — |
Q4 2024 | Oct 16, 2024 | — | $-1.50 | — | — |
Q3 2024 | Jul 17, 2024 | — | $1.59 | — | — |
Q2 2024 | Apr 26, 2024 | — | $-0.06 | — | — |
Q4 2023 | Dec 31, 2023 | — | $-1.98 | — | — |
Q3 2023 | Sep 30, 2023 | — | $-0.71 | — | — |
Q2 2023 | Jun 30, 2023 | — | $1.69 | — | — |
Q1 2023 | Mar 31, 2023 | — | $-0.78 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-1.06 | — | — |
Q3 2022 | Sep 29, 2022 | — | $-0.06 | — | — |
Q2 2022 | Jun 29, 2022 | — | $-0.41 | — | — |
Q1 2022 | Mar 30, 2022 | — | $-0.35 | — | — |
Q4 2021 | Dec 30, 2021 | — | $-0.43 | — | — |
Q4 2021 | Nov 24, 2021 | — | $-5.00 | — | — |
Q2 2020 | May 7, 2020 | — | $-10.13 | — | — |
Latest News
Loading news...
Frequently Asked Questions about FLERIE.ST
What is FLERIE.ST's current stock price?
Flerie AB (publ) (FLERIE.ST) is currently trading at $36.35 per share. The stock has moved -1.76% today.
What is the analyst price target for FLERIE.ST?
No analyst price targets are currently available for this stock.
What sector is Flerie AB (publ) in?
Flerie AB (publ) operates in the Healthcare sector, specifically within the Drug Manufacturers - General industry. The company is traded on the STO exchange.
What is FLERIE.ST's market cap?
Flerie AB (publ) has a market capitalization of $2.84 billion, making it a mid-cap company.
Does FLERIE.ST pay dividends?
No, Flerie AB (publ) does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorBINV.ST
BioInvent International AB (publ)
$29.75
Mkt Cap: $2.0B
DMYD-B.ST
Diamyd Medical AB (publ)
$10.08
Mkt Cap: $1.4B
DVYSR.ST
Devyser Diagnostics AB (publ)
$113.80
Mkt Cap: $1.9B
EGTX.ST
Egetis Therapeutics AB (publ)
$5.30
Mkt Cap: $1.9B
HNSA.ST
Hansa Biopharma AB (publ)
$31.24
Mkt Cap: $2.6B
HUM.ST
Humana AB (publ)
$49.65
Mkt Cap: $2.4B
IMP-A-SDB.ST
Implantica AG
$48.70
Mkt Cap: $2.8B
ORX.ST
Orexo AB (publ)
$27.30
Mkt Cap: $0.9B
SANION.ST
Saniona AB (publ)
$20.60
Mkt Cap: $2.8B
VICO.ST
Vicore Pharma Holding AB (publ)
$11.08
Mkt Cap: $2.6B
Explore stocks similar to FLERIE.ST for comparison